Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:        
Net loss $ (5,411) $ (4,821) $ (10,504) $ (9,867)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 41 55 83 107
Amortization of right-of-use assets     121 108
Unrealized gain on investment 3 23 0 5
Share-based compensation expense     254 510
Changes in operating assets and liabilities:        
Trade and other receivables     (50) 0
Other assets     388 470
Trade and other payables     (50) 1,146
Accrued employee benefits     (5) (5)
Lease liabilities     (125) (96)
Net cash used in operating activities     (9,888) (7,622)
Cash flows from financing activities:        
Proceeds from issuance of common stock, pre-funded warrants, and common warrants     17,884  
Shares and pre-funded warrant issuance costs     (1,869)  
Net cash provided by financing activities     16,015  
Effects of exchange rate changes on cash, cash equivalents, and restricted cash     348 182
Net increase (decrease) in cash, cash equivalents, and restricted cash     6,475 (7,440)
Cash, cash equivalents, and restricted cash, beginning of period     4,076 19,783
Cash, cash equivalents, and restricted cash, end of period $ 10,551 $ 12,343 10,551 12,343
Supplemental disclosure of cash flow information:        
Re-measurement of operating lease right-of-use assets and liabilities     $ 0 $ 794